Bucheon St. Marys Hospital

Richmond, Virginia 23229

0 studies enrolling now · 2 studies all time

What they study most

Liver Fibrosis Due to NASH

Studies at this site

• Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) — Stopped early
• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH — Stopped early